BostonGene to Present Twelve Abstracts at 66th ASH Annual Meeting
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced that 10 of its abstracts have been selected for poster presentations, and two will be featured for online publication at the 66th American Society of Hematology (ASH) Annual…
Vevo Therapeutics Partners with Parse Biosciences to Create 100 Million Cell Atlas for AI Drug Discovery
Parse Biosciences, a leader in accessible and scalable single-cell sequencing solutions, has announced the creation of the world’s largest single-cell dataset to date, comprising 100 million cells. This milestone was achieved in just one month using Parse Biosciences’ GigaLab platform,…
Veracyte’s Decipher Prostate Test Now Only Gene Expression Test in NCCN® Guidelines
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced that its Decipher Prostate Genomic Classifier is now the only gene expression test included in version 1 of the 2025 NCCN® Clinical Practice Guidelines in Oncology (NCCN Guidelines®). It is…
QIAGEN Hits 1,000 Milestone for EZ2 Connect Sample Prep Instrument
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a major milestone, surpassing 1,000 placements of its EZ2 Connect automated sample preparation instrument, a key advancement in the EZ1 instrument line. Launched in 2021, the EZ2 Connect has quickly become…
Lyra Health Appoints Jennifer Schulz as CEO
Lyra Health, a leader in innovative Workforce Mental Health solutions for employers and health plans, is excited to announce that Jennifer Schulz will join the company as Chief Executive Officer and Board member, effective January 13, 2025. Schulz will succeed…
Exai Bio Appoints Karen E. Knudsen to Board of Directors
Exai Bio, a leading RNA- and AI-based liquid biopsy company, has announced the appointment of Karen E. Knudsen, MBA, PhD, to its board of directors. Knudsen, the former CEO of the American Cancer Society (ACS) and its affiliate, the American…
Foresight Diagnostics Launches SHORTEN-ctDNA Trial for DLBCL Treatment Duration
Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, has announced the launch of the SHORTEN-ctDNA clinical trial at Columbia University. The study aims to assess the use of Foresight CLARITY™ MRD detection for real-time treatment optimization…
Presidio Medical Appoints Richard J. Buchholz to Board of Directors
Presidio Medical, Inc., a clinical-stage company focused on developing a groundbreaking neuromodulation platform, is excited to announce the appointment of Richard J. Buchholz to its Board of Directors. Rick currently serves as the Chief Financial Officer at Inspire Medical Systems,…
University Medical Devices Launches Innovative Nasal Lavage Collection Device for Faster, Higher-Sensitivity Samples
University Medical Devices (UMD), a leader in healthcare technology innovation, has announced the launch of its first specimen collection solution, MicroWash. Developed at the onset of the COVID-19 pandemic, MicroWash offers a comfortable and highly sensitive nasal lavage collection method,…
OnMed to Debut at CES 2025, Revolutionizing Healthcare Access for Underserved Communities
OnMed, a leading tech-enabled hybrid care company, is set to debut its innovative OnMed CareStation at CES 2025 in Las Vegas, Nevada. This breakthrough solution is transforming how underserved communities access essential healthcare, positioning OnMed as a pioneer in closing…
GE HealthCare Expands Effortless Recon DL Portfolio with Advanced Image Reconstruction
At the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, GE HealthCare (Nasdaq: GEHC) introduced three new advanced deep learning image processing and reconstruction solutions as part of its Effortless Recon DL portfolio. Designed to address the…
Hyperfine Highlights Clinical Study Results for Swoop® System at RSNA 2024
Hyperfine, Inc. (Nasdaq: HYPR), a leader in health technology, showcased data at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, highlighting the growing use of AI-powered portable MR brain imaging. Eleven prominent institutions presented clinical studies…